Understanding the pathology of the fem ale reproductive system with respect to toxicology requires a basic understand ing of morphology and function of the system over time because the nature of the female reproductive system is cyclical. Thus, the morphology and the endocrinology is dependen t on age and time, as form follows function and function follows form . The life span of the rodent is used as an outline to present an overview of key morphological and endocrinological events important for toxicologic pathologists to consider in study evaluations. Environmental and pharmaceu tical compound s differentially impact the organs individually and/or the system in its entirety in a time-and dose-depen dent way. Exam ples are used to illustrate the consequenc es of exposures at different times and with different outcomes.
INTRODUCTION
The fem ale reproductive system is intrinsically cyclical. The nature of the cyclicity may be de ned in stochastic or chaotic mathematical terms, but the characteristics are certainly dependent on time (age). Toxicant exposures, stress, and/or levels of nutrition can alter form and function of the reproductive components in m any ways, including altering the development of the organs; altering the endocrine, paracrine, and autocrine signaling cross-talk loops; and altering the m olecular setpoints at which cells of the reproductive system respond to growth, differentiation, and death signals. As the reproductive system is dynamic, there are also critical periods in which exposures to chem ical and other environm ental stresses may cause signi cant damage or periods in which these same exposures may cause no effect. Thus, tim ing of exposure in the cycle is critical.
CORRELATION OF FORM AND FUNCTION OVER THE LIFE STAGES OF THE RODENT Prenatal Development
The female reproductive system develops by design. In the XX female rodent, the ovar y proper develops in the gonadal ridge of the mesoderm layer after the primoridal germ cells arrive from the yolk sac (around gestational day 11.5 in the mouse) with the tubular organs arising from the Mü llerian duct (beginning around day 14) ( Figure 1 ). The oogonia undergo a series of mitotic proliferations and then arrest in meiotic prophase (diplotene) to become a nonreplicating, nonrenewing population of oocytes. This occurs by postnatal day 5 in the mouse and rat (1) . Toxicants that speci cally target the oocyte can have an irreversible negative impact on fertility and cause premature ovarian failure and aging with consequences of secondary diseases associated with reproductive aging, including cancers. Given this potential action of reproductive toxicants, a major issue in hazard identi cation and risk assessment is determining which chemicals may be oocyte toxicants. Currently, follicle counts in step sections of ovaries are being done (2), but an ongoing issue for pathologists and reproductive toxicologists is to determ ine whether this procedure will ultim ately prove accurate or adequate.
In the gonad, granulosa cells or Sertoli cells arise from a comm on progenitor sex cord cell. W hile both cell types serve to support the germ cell and both cells types have many similar receptors, the ultimate fate of the granulosa cell is different from that of the Sertoli cell. Granulosa cells have a prolonged but nite life span in the female. Once a follicle begins growing and granulosa cells proliferate, most of the cells will die through apoptosis. Less than one-third of follicles and the granulosa cells will contribute to the ovulatory pool and subsequently develop into luteal cells after ovulation. In contrast, Sertoli cells have an inde nite life span in support of spermatogenesis. Estrogen regulation appears critical in this programming of cell fate because dysm orphogenesis or transdifferentiation of granulosa cells to Sertoli cells has been described in the adult ovaries of m ice de cient in both estrogen receptors and (5) .
We also recently reported that prom otion by TCDD after DEN initiation in female adult Sprague-Dawley rats altered a fundamental apoptotic program of granulosa cells allowing for their survival and transdifferentiation to the m ale-patterned Sertoli cell and subsequent forma-FEM ALE REPRODUCTIVE PATHOLOGY tion of Sertoli cell tumors (10) . As TCDD has been shown to down-regulate ER in the liver and uterus (24) , TCDD m ay also interact and down-regulate ER in the granulosa cells as it prom otes tumor growth. TCDD activates the aryl hydrocarbon receptor (AhR), which is present in undifferentiated granulosa cells. Thus, AhR may also be an important regulator of cell fate in the gonad. Such receptor pathways like ER and AhR m ay be activated by endocrine-disrupting chem icals to alter developmental programs and/or contribute to the development of cancers. Indeed, tissues in their early stages of development appear to be m ost sensitive to environmental estrogens and other endocrine-disrupting chemicals.
The developm ent of tubular organs are also dependent on hormones and can be altered by estrogenic compounds (11) . The vagina forms at the caudal end of the Mü llerian duct system and the epithelium of the urogenital ridge. The distal end rem ains incom pletely formed until the onset of puberty. The completion of the tract, ''vaginal opening,'' represents a reliable marker of puberty. Additionally, the tim ing of vaginal opening and/or the opening can be altered by exposures to endocrine-disrupting chemicals (3, 4, 15) .
DEVELOPMENT OF THE HYPOTHALAMIC-PITUITARY-
OVARIAN AXIS AND THE ONSET OF PUBERTY IN THE FEMALE The basic physiological mechanisms underlying the onset of puberty in mammals are conserved across species. These include the development of functional gonadotropin-releasing horm one (GnRH) neurons, the control of GnRH neurons by neurotransmitters, the release of GnRH into the portal vasculature to the adenohypophysis, the initiation of gonadotropin secretion (also modulated by hypothalam ic factors), stimulation of ovarian function by gonadotropins, responsiveness to negative and positive feedback effects of steroids, and responses to other ovarian factors at the level of the hypothalamus and adenohypophysis (21, 22) .
During development, the tropic effects of GnRH on pituitary gonadotropes allows for their differentiation into endocrine cells. Pituitary-luteinizing hormone (LH) levels parallel the fetal rise in GnRH, follicle-stimulating hormone (FSH) is not detectable until gestational days 19 -21 (in the rat), and circulating levels of both gonadotropins rem ain low until birth (21, 22) . Pituitary responsiveness to GnRH is greater in infantile compared with juvenile rats (25) . Furthermore, in the infantile rat, gonadotropin secretion is insensitive to estradiol negative feedback because high levels of circulating alpha-fetoprotein (AFP) bind the small amount of estrogen in circulation. Taken together, a slow frequency of GnRH secretion, high pituitary sensitivity to GnRH, and lack of estradiol negative feedback culminate in an increased secretion of FSH during the infantile period. Prior to puberty, the GnRH neurons are capable of secreting episodically; however, they are under central inhibitory control. Dopamine and norepinephrine turnover rates increase during juvenile development, and prior to puberty there is a change in the response to catecholam ines from an inhibitory effect to a stimulatory effect (21) . Blocking of catecholamine synthesis at 16 days of age increases plasma LH; however, the same treatm ent at 30 days of age results in inhibition of LH secretion. The pattern of gonadotropin release during juvenile development is also in uenced by pituitary responsiveness to GnRH.
During the juvenile period, the hypothalamic-pituitaryovarian (H -P-O) axis becomes responsive to the negative feedback effects of estradiol, and the capacity of GnRH neurons to release GnRH increases gradually in an estrogen-dependent manner (between 22 and 34 days old in the rat and m ouse). During this transition, maturation of estradiol negative and positive feedback m echanisms occur. Estradiol negative feedback becomes maximally effective during the juvenile period when levels of AFP have fallen. Prior to this period, testosterone and androstenedione play leading roles in negative feedback on gonadotropin secretion. High levels of estradiol will not induce a surge of LH prior to 3 weeks of age, after which the sensitivity of the H -P axis to the stim ulator y effects of estrogen increase as the animal matures. With maturation, development of the estrogen-positive feedback response is demonstrated by both an increased magnitude of the LH surge and a decreased tim e to surge relative to estrogen challenge. Before endogenous estrogen can reach high enough levels to induce a gonadotropin surge, there must be adequate stimulation of the ovar y by highfrequency pulses of LH driven by the maturation of the GnRH -LH axis.
The ovary is relatively insensitive to gonadotropins during the rst week of postnatal life, and the initiation of follicular growth is gonadotropin independent. Maintenance of follicular growth depends on continuous exposure to gonadotropin (23) . FSH may have actions on the ovar y as early as day 5 that are necessary for subsequent acquisition of FSH receptors. During the second week of life (infantile stage), many small follicles begin to move into m ore advanced stages of development, and ovarian production of estrogen increases. Completion of follicular growth takes 15-19 days for follicles to reach a preovulator y or ovulatory condition at puberty and when adequate levels of gonadotropins are present.
Two additional pituitary horm ones, prolactin (Prl) and growth horm one (GH), have been shown to contribute to ovarian maturation by facilitating the effects of gonadotropins. An adult growth pattern of GH secretion is established around the time of puberty, and Prl goes through changes in secretory patterns between the juvenile period and puberty. Prl can accelerate the onset of puberty in fem ale rodents. Chronic stimulation of Prl release results from dopaminergic inhibition and can advance the onset of puberty by increasing progesterone and estrogen secretion in response to gonadotropins. Conversely, inhibition of Prl secretion (eg, ergot alkaloid bromoergocriptine, which activates dopaminergic receptors) delays the onset of puberty by reducing the steroidal response to gonadotropins. GH also plays a facilitatory role in the onset of puberty. Suppression of GH release can delay vaginal opening and rst ovulation. Some actions of GH are direct actions at the level of the pituitary; however, much evidence indicates that they are mediated by IGF-I produced in granulosa cells. The timing of puberty onset is regulated by multiple interrelated events, som e of which are initiated during the infantile period (21, 22, 25) . During the fth week of postnatal life, basal levels of LH and LH pulse amplitude becom e greater in the afternoon compared with morning levels. This diurnal change in the pattern of LH release has a central regulatory component that leads to increased amplitude in LH pulses and an ovarian (estrogen)-dependent component that perm its ''minisurge'' levels of LH in the afternoons. Prl is also secreted episodically, and during developm ent Prl levels becom e increasingly elevated in the afternoons com pared with morning levels. This afternoon rise in Prl secretion is also centrally driven, as it occurs in the absence of the ovar y. The biological activity in circulating gonadotropins m ay also play a role in the timing of puberty. Diurnal changes in pulsatile release of LH at the initiation of puberty result from the activation of GnRH neurons. These changes in LH secretion are critical for the pubertal transition to occur because they stimulate the ovary to produce increasing levels of estradiol. Subtle increases in estrogen allow for the afternoon ''minisurge'' of LH to occur, which then further activates the ovary. Following the establishm ent of the diurnal pattern of LH release, a series of events occur leading up to and culminating in the preovulator y gonadotropin surge and rst ovulation.
The occurrence and timing of the LH surge marks the climax of female neuroendocrine developm ent, and this event depends on the completion of ovarian maturation. The preovulatory surge can occur only in the presence suf cient levels of estradiol sustained for a suf ciently long period of time, and the ability of the ovary to secrete suf cient estradiol is the key event that determines the timing of puberty (25) . Estrogen evokes the surge by acting at the hypothalamus, evoking GnRH release, and at the anterior pituitary, sensitizing the gonadotropes to the stimulatory effects of GnRH. During the end of juvenile developm ent, there is a diurnal change in basal secretion of LH and magnitude of LH pulses independent of ovarian actions. These changes stim ulate the ovar y to produce more estrogen, leading to the developm ent of ''minisurges'' of LH secretion that further stim ulates the ovary. The preovulatory discharge of GnRH evokes a surge in gonadotropin secretion. This is determ ined primarily by positive feedback effects of increased output of ovarian estrogen from the stim ulated ovar y. The preovulatory surge of gonadotropins induces the rst ovulation on proestrus. Estrogen stimulates the vaginal epithelium, resulting in vaginal opening.
The juvenile period is a time to establish set points for the endocrine feedback loops of the adult system. A series of studies designed to expose rats during these critical periods have recently been com pleted by Chapin et al (4) . Methoxychlor (MXC), a pesticide that has been in use for a half century, has estrogenic effects in the fem ale reproductive system, depending on time of exposure. Indeed, one of the m ost interesting ndings in the m ultigeneration study is evidence that M XC altered feedback interaction and m aturation of the H -P-O axis during development. MXC treatment resulted in increased serum estrogen-to-progesterone ratios in the 2 high-dose (50 and 100 m g/kg) groups but not in the low -dose (5 mg/kg) group. However, FSH levels were signi cantly suppressed in all treatment groups at estrus, including the 5mg/kg M XC group. The alteration in FSH is attributed to the estrogenic pesticide effects on pituitary gonadotropes during development even at the lowest exposure level. At higher doses, M XC caused complete reproductive dysfunction.
REPRODUCTIVE CYCLES Assessment of Cyclicity
Tem poral coordination of the horm ones manifests as a cycle. The prim ate (including hum ans) has a 28-day cycle characterized by 4 -7 days of menstruation during the follicular phase and a luteal phase. The rat and m ouse have estrous cycles that vary from 4 to 14 days but typically are characterized as 4-or 5-day cycles. The length and horm onal characteristics of the cycle vary between species and strain (Figures 3, 4, and 5 ). The short cycle of the rat and mouse is attributed to a lack of a luteal phase and functional, progesterone-secreting corpora lutea. The change in horm ones over the cycle results in morphological changes in the ovar y, uterus, and vagina, all of which can be used to determ ine the stage of cycle ( Figure 6 ). As such, the days of estrous cycle de ned by these hormonal variations and resulting morphological changes in reproductive organs are proestrus, estrus, metestrus, and diestrus 1 and diestrus 2, with ovulation during estrus FEM ALE REPRODUCTIVE PATHOLOGY (18, 19) . Prolonged cycles may occur during ''pseudoprgenancy.'' Pseudopregnancy is characterized hormonally as a progesterone-elevated state due to secondary surges of LH and/or prolactin in the cycle and may be induced by stimulation of the cervix with neurogenic response of the pituitary hormones or occur spontaneously.
Such variations need to be considered when evaluating potential ovarian toxicants.
Hormone production in the female is described as the ''two-cell, two-gonadotropin theor y'' (17, 20) , in which FSH stim ulates ovarian granulosa cells of follicles and LH stimulates the surrounding thecal cells of follicles. Increasing levels of FSH increase the num ber of FSH receptors on the granulosa cells and the production of progesterone. Progesterone is a substrate for the thecal cells, which under LH stim ulation convert progesterone to androgens. Androgens diffuse through the basem ent membrane to the granulosa cell and have 2 actions on the granulosa cell (16) . First, androgens synergize with FSH and IGF1 to induce aromatase P -450, the enzyme that converts testosterone to estradiol. Second, these androgens are the substrate for arom atase conversion to estradiol.
As an autocrine response to this horm onal m ilieu, granulosa cells acquire their own LH receptors. As granulosa cells become responsive to LH, these cells also produce m ore estradiol. Thus, aromatase activity and consequently estradiol production become linked to the LH surge (14) . However, arom atase is rapidly down-regulated in the granulosa cell after the LH surge (23) .
TOXICANTS THAT AFFECT THE REPRODUCTIVE CYCLE OF THE ADULT The naturally cycling Sprague-Dawley rat has been used to determine how some reproductive toxicants alter cyclicity and ovarian function. The ovary is a complex tissue with an intricate set of independent and interdependent processes, each of which is a potential target for perturbation by environmental, occupational, or therapeutic agents. Of the many possible chemical-related effects, disruption of events leading to ovulation and corpora lutea formation likely represent critical target sites for chemical insult. Detailed descriptions of the site and mechanism have been reviewed elsewhere (6, 8, 11) , but the effects of 2 chemicals are brie y described here to illustrate effects of toxicants on adult cycling animals.
Phthalates are the m ost abundant synthetic chemicals found in the environment and are of human health concern because of their potential to disrupt endocrine systems. These leachable, volatile chem icals are added to all plastics to impart exibility and are of concern prim arily because people are exposed to phthalates on a daily basis in low levels through inhalation and derm al exposure. In th e S pragu e -D aw ley rat, di -(2 -eth ylhexyl)phthalate (DEHP) speci cally targets ovarian granulosa cells in preovulatory follicles, resulting in hypoestrogenic, hypoprogestinic, anovulatory cycles (9) . The resulting ovarian pathology was characterized as multiple follicular cysts. In DEHP-treated rats, the prim ary insult to the granulosa cell resulted in a 30 -40% suppression of serum estradiol levels and an increase in FSH levels due to lack of negative feedback control from estrogen. Since estradiol production in granulosa cells is dependent on aromatization of a paracrine source of androstenedione, it is likely that DEHP suppresses granulosa cell estradiol production by altering arom atase availability or amount in the granulosa cell (12) . Ethylene glycol monom ethyl ether (EGME) is a widely produced and widely used organic solvent. EGME and its active metabolite 2-methoxy acetic acid (MAA) are well-characterized testicular toxicants, and human exposure to EGME has been of historic concern because of its known reproductive toxicity in men. The ovary is a target organ for EGM E in the female (7) . Speci cally, the ovarian luteal cell is a target of EGME, and the reproductive toxicity in the fem ale rat is m anifested morphologically as luteal cell hypertrophy and functionally as progesterone hypersecretion. Pituitary hormone levels, including FSH, LH, and prolactin, remained at baseline levels in EGM E-treated rats compared to cycling controls, suggesting that EGME targeted the ovary rather than affecting luteal function through the stim ulation of pituitary hormones.
Questions remain as to the long-term consequences of exposures to these and other reproductive toxicants during adulthood. For example, would the ovary and the horm onal signals re-establish normal cyclicity if exposure was discontinued? Would cyclicity be re-established but be irregular, and what would be the consequences of irregular cycles? What would be the long-term effects on fertility if normal or irregular cycles were re-established? Such questions m ay best be addressed through compar-ative approaches using animal models, mathematical models, and epidem iological data, and much of our future laborator y efforts will be directed toward answering these questions.
AGE-RELATED ABERRATIONS IN ESTROUS CYCLICITY AND THE TRANSITION INTO REPRODUCTIVE SENESCENCE
The mechanisms by which the reproductive system ages are still unclear. There is mounting evidence for a role of neuroendocrine function in determining the timing of m enopause in women and reproductive senescence in rodents (26, 27) . It is probable that age-related changes in the function of GnRH neurons and neuroendocrine system s that in uence their function precede readily apparent changes in reproductive capacity, such as irregular estrous cycles, increased rate of follicular atresia, and eventual exhaustion of ovarian follicles. In assessing reproductive senescence, it is important to consider that subtle changes in neuronal populations that control biological rhythms precede and m ay also preclude the transition from regular reproductive cycles to aberrant cycles.
Maximum fertility and regularity of estrous cycles in C57BL/6J mice occur between 4 and 8 months of age (13) . The earliest signs of reproductive aging in mice are increases in variability and length of the estrous cycle, FEM ALE REPRODUCTIVE PATHOLOGY beginning at around 9 -10 months of age. The number of ova shed at ovulation is preserved up to 14 months of age; however, litter size is reduced. Cyclicity ceases between 10 and 14 months of age followed by a state of persistent vaginal corni cation and eventually persistent diestrus. The pattern of events leading to reproductive senescence is sim ilar in rats. In general, Sprague-Dawley rats begin exhibiting irregular cycles by 8-12 months of age and become acyclic by 17-21 months of age.
Several factors contribute to the variability in tim ing of reproductive senescence in rodents, including the strain of rat or mouse, environm ental factors, and whether pregnancy occurred. These are the sam e factors that contribute to the development of age-related diseases and cancers in particular. Assessing such changes is technically challenging and has to involve approaches such as measuring episodic secretion of gonadotropins, determ ining other dynamic horm onal pro les, quantifying changes in the patterns of speci c neurotransm itters and neuromodulators, and molecular approaches to studying gene activation in speci c neuronal populations. However, assessing such changes will be critical to advance our understanding of the comm onalties between the aging of the reproductive system and its in uence on life overall.
